James Steven P
Insider CIK 1243025 · OCRX Director · ONTY Director · ALLK Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALLK Allakos Inc. | D To issuer deriv | 2025-05-15 | 2025-05-15 | 55,380 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | D To issuer deriv | 2025-05-15 | 2025-05-15 | 18,800 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | D To issuer deriv | 2025-05-15 | 2025-05-15 | 16,000 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | D To issuer deriv | 2025-05-15 | 2025-05-15 | 7,700 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | D To issuer deriv | 2025-05-15 | 2025-05-15 | 7,700 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | D To issuer deriv | 2025-05-15 | 2025-05-15 | 99,590 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | D To issuer deriv | 2025-05-15 | 2025-05-15 | 86,762 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | D To issuer deriv | 2025-05-15 | 2025-05-15 | 41,000 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | A Award deriv | 2024-05-24 | 2024-05-29 | 41,000 | — | $0 | 41,000 | SEC↗ |
| ALLK Allakos Inc. | A Award deriv | 2023-05-25 | 2023-05-30 | 86,762 | — | $0 | 86,762 | SEC↗ |
| ALLK Allakos Inc. | A Award deriv | 2022-05-25 | 2022-05-27 | 99,590 | — | $0 | 99,590 | SEC↗ |
| ALLK Allakos Inc. | M Exercise deriv | 2021-09-28 | 2021-09-29 | 4,000 | — | $0 | 55,380 | SEC↗ |
| ALLK Allakos Inc. | S Sale | 2021-09-28 | 2021-09-29 | 4,000 | $108.12 | $432.5K | 0 | SEC↗ |
| ALLK Allakos Inc. | M Exercise | 2021-09-28 | 2021-09-29 | 4,000 | $0.53 | $2.1K | 4,000 | SEC↗ |
| ALLK Allakos Inc. | A Award deriv | 2021-05-25 | 2021-10-14 | 7,700 | — | $0 | 7,700 | SEC↗ |
| ALLK Allakos Inc. | M Exercise deriv | 2021-03-16 | 2021-03-17 | 3,500 | — | $0 | 59,380 | SEC↗ |
| ALLK Allakos Inc. | S Sale | 2021-03-16 | 2021-03-17 | 3,500 | $121.65 | $425.8K | 0 | SEC↗ |
| ALLK Allakos Inc. | M Exercise | 2021-03-16 | 2021-03-17 | 3,500 | $0.53 | $1.9K | 3,500 | SEC↗ |
| ALLK Allakos Inc. | A Award deriv | 2020-05-26 | 2020-05-28 | 7,700 | — | $0 | 7,700 | SEC↗ |
| ALLK Allakos Inc. | A Award deriv | 2019-06-06 | 2019-06-11 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 13,927 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | U Tender | 2018-03-09 | 2018-03-13 | 13,677 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 10,000 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 12,500 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 20,000 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-11 | 12,500 | $1.52 | $19.0K | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2017-09-24 | 2017-09-26 | 2,375 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2017-09-24 | 2017-09-26 | 594 | $3.94 | $2.3K | 13,677 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2017-09-24 | 2017-09-26 | 2,375 | — | $0 | 14,271 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2017-06-24 | 2017-06-27 | 9,058 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2017-06-24 | 2017-06-27 | 2,265 | $3.78 | $8.6K | 11,896 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2017-06-24 | 2017-06-27 | 9,058 | — | $0 | 14,161 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award | 2017-06-20 | 2017-06-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2017-06-12 | 2017-06-13 | 2,148 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2017-06-12 | 2017-06-13 | 2,148 | — | $0 | 5,640 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2017-06-12 | 2017-06-13 | 537 | $3.34 | $1.8K | 5,103 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-06-09 | 2017-06-13 | 13,927 | — | $0 | 13,927 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2017-03-12 | 2017-03-14 | 4,656 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2017-03-12 | 2017-03-14 | 4,656 | — | $0 | 4,656 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2017-03-12 | 2017-03-14 | 1,164 | $4.35 | $5.1K | 3,492 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2016-06-24 | 2016-06-28 | 54,347 | — | $0 | 54,347 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2016-06-14 | 2016-06-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2015-09-24 | 2015-09-28 | 14,245 | — | $0 | 14,245 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2015-06-18 | 2015-06-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2015-06-12 | 2015-06-16 | 12,886 | — | $0 | 12,886 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2015-03-12 | 2015-03-13 | 27,932 | — | $0 | 27,932 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2014-09-17 | 2014-09-18 | 20,000 | — | $0 | 20,000 | SEC↗ |